These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5389145)

  • 21. 4-Threonine-oxytocin: a more active and specific oxytocic agent than oxytocin.
    Manning M; Sawyer WH
    Nature; 1970 Aug; 227(5259):715-6. PubMed ID: 5432071
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
    Dyckes DF; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1973 Jul; 16(7):843-7. PubMed ID: 4725931
    [No Abstract]   [Full Text] [Related]  

  • 23. The deamino derivatives of (4-threonine)-oxytocin and (4-threonine)-mesotocin; analogs possessing a surprising spectrum of diminished pharmacological activities.
    Manning M; Coy EJ; Sawyer WH
    Experientia; 1971; 27(11):1372-4. PubMed ID: 5167408
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vasopressin and Oxytocin. Physiological and pharmacological basis for the clinical use of the posterior pituitary gland hormones].
    Rauch R
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2611-4. PubMed ID: 4901915
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and some pharmacological properties of 8-L-methionine-oxytocin.
    Bodanszky M; Chandramouli N; Martinez J; Walter R
    J Med Chem; 1979 Mar; 22(3):270-3. PubMed ID: 423209
    [No Abstract]   [Full Text] [Related]  

  • 26. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
    Roy J; Roy U; Gazis DC; Schwartz IL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 29. A neurohypophyseal hormone analog with selective oxytocin-like activities and resistance to enzymatic inactivation: an approach to the design of peptide drugs.
    Walter R; Yamanaka T; Sakakibara S
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1901-5. PubMed ID: 4525300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-Isoleucine-oxytocin and deamino-2-isoleucine-oxytocin: their synthesis and some of their pharmacologic activities.
    Branda LA; Hruby VJ; Du Vigneaud V
    Mol Pharmacol; 1967 May; 3(3):248-53. PubMed ID: 6068341
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of decreasing the size of the ring present in deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-mercaptoacetic acid-oxytocin.
    Jarvis D; Du Vigneaud V
    J Biol Chem; 1967 Apr; 242(8):1768-71. PubMed ID: 6067284
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on pharmacological and biochemical properties of deamino-dicarba-[GLY-7]-oxytocin (Y-5350).
    Oka T; Nakanishi A; Okada T
    Jpn J Pharmacol; 1975 Feb; 25(1):15-24. PubMed ID: 1152307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
    Walter R; Havran RT; Schwartz IL
    J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 37. (2,4-Dileucine)exytocin. A polypeptide with natrituretic and diuretic activities, and an inhibitor of the oxytocic response of oxytocin.
    Hruby VJ; Chan WY
    J Med Chem; 1971 Nov; 14(11):1050-1. PubMed ID: 5115201
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and some biological properties of 4-valine-oxytocin and 1-deamino-4-valine-oxytocin.
    Du Vigneaud V; Flouret G; Walter R
    J Biol Chem; 1966 May; 241(9):2093-6. PubMed ID: 5949929
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis of [8-alpha-hydroxyisocaproic acid]oxytocin. Biological activities and comparison of its in vivo uterine actions to those of deamino-[8-alpha-hydroxyisocaproic acid]oxytocin, deamino-oxytocin and oxytocin.
    Roy J; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Aug; 16(2):106-10. PubMed ID: 7461893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biofunctional evaluation of a hydrogen bond stabilizing the beta-turn in the acyclic part of oxytocin.
    Roy J; Johnson M; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1980 Jul; 16(1):55-60. PubMed ID: 7192272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.